Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
about
Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancerRadiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesAdjuvant chemotherapy for rectal cancer: Is it needed?Management of colorectal cancerCurrent treatment of rectal cancer adapted to the individual patientSTAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyNeoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancerReview of systemic therapies for locally advanced and metastatic rectal cancerCurrent debate in the oncologic management of rectal cancer.What Do We Learn from Spheroid Culture Systems? Insights from Tumorspheres Derived from Primary Colon Cancer TissueSystematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer.Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data.Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer.Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)Neoadjuvant therapy before surgical treatmentThe Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.Changes of Microrna Levels in Plasma of Patients with Rectal Cancer during Chemoradiotherapy.Overview of radiation therapy for treating rectal cancer.Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer.Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials.Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma.Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis.A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis.STED super-resolution microscopy of clinical paraffin-embedded human rectal cancer tissue.Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues.Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation.Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical SurgeryTumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.Severe myositis of the hip flexors after pre-operative chemoradiation therapy for locally advanced rectal cancer: case report.
P2860
Q24186443-4EDA8BD4-2A2B-4E29-8C5F-2E4099261E32Q26738806-15254EBA-9D9A-445C-820D-E09523F9CB21Q26775099-327E295A-1915-4521-B29C-148DDFE6344BQ26823550-4EB0469B-9AF4-4299-BD70-3CCABF6897EDQ26824553-D6DC9030-376C-4F5C-8A6D-215F13A1C486Q27003190-3562BB90-9C37-4E55-90A9-01A59258BD67Q27003878-62AC7438-D673-4CF6-9AF7-32B81EC995C5Q27021105-7B6F80DB-92E4-45BE-9340-508E24C58831Q28072948-A6DBF681-8DA6-498A-B859-6A066831BD85Q28552232-ED094A43-DFEA-4753-9A62-4269C915EB4BQ30235044-8DC596F7-66DA-4F29-81FB-7197FA30E456Q30578568-D17C8017-789A-42A0-B093-2B9EBAFF8C44Q30744596-EB84CDD5-6DB0-49CA-A739-E2B2D76C078FQ31138958-26BE0BD9-BE7C-4DF1-8FE0-E4C4E938F787Q33411783-CF0D77FD-CE3A-46BB-BAE1-44C858B1A9FAQ33424898-ADFDA476-026E-4186-A57A-83E637FF8C91Q33432180-F8781717-0364-4E23-AF9C-860BC4EA9A31Q33433227-729AA4FB-B60B-49BD-B55E-48F50B40C2DFQ33697924-891AF3F8-031C-47EC-ACA6-3A202B606094Q33776733-3B6265A3-B0E6-47AA-AAE7-144F12438B2CQ33838484-94FA97FC-765F-43E6-BE74-701D7CF85E1DQ34136267-55597DE8-19B1-4671-94FE-4DABF870971BQ34483466-D74165D3-F157-4A51-82C0-4E22C441E648Q34499632-5AFBD306-B235-4E2F-B1F5-B1FB6F63AF40Q34630015-DA5670AD-98B7-437F-A6DF-5906CCE166FAQ34655838-D041EF36-4959-4A69-8E74-7A378D0EFEF7Q34927668-3E9B7D86-08BE-499F-ACF3-1BBE41095C21Q34943505-6B1F1B6A-481F-46D5-891B-5A0EAD6522C8Q35033392-5488C8B5-E34D-4C9D-A124-243A9C22423EQ35051918-699CA37D-5549-4050-AA21-A2230AF6D180Q35206934-0DC9D90C-86FE-46EF-BA11-4603E561E10FQ35475535-EFB75405-7D2A-49C0-85AE-082BF7308E48Q35526713-CB07BB1A-1A85-4A80-B285-24F821B03A15Q35680327-C70D1A9E-728D-4BB2-9389-B2F1AE1F2BDDQ35709494-BCF207F1-6EA9-402B-88AF-E59B83DE8DF9Q35793914-348FA67D-0BD6-4F85-9F21-A6B382A251E7Q35815373-8F062BED-AB56-4B30-8710-91FD7B13E1AFQ35820586-4F4176EA-35F3-444C-B993-494F5D5CBAF1Q35929864-01305EEA-68C5-4745-ABD8-2C81BE6E2C55Q35965169-351B5FC4-FB5E-4845-B502-46B1643AD739
P2860
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@ast
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@en
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@nl
type
label
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@ast
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@en
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@nl
prefLabel
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@ast
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@en
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@nl
P2093
P921
P1433
P1476
Preoperative chemoradiotherapy ...... O-04 randomised phase 3 trial.
@en
P2093
Anke Schlenska-Lange
Christian Wittekind
Clemens Hess
Dirk Arnold
Fritz Lindemann
Gerhard G Grabenbauer
German Rectal Cancer Study Group
Gunnar Folprecht
Hans Hoffmanns
Hans-Rudolf Raab
P304
P356
10.1016/S1470-2045(12)70187-0
P577
2012-05-23T00:00:00Z